Clinical Trial Update: Comparison of nanOss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral Spine [NA]

View source ↗

Summary

This completed trial compared nanOss Bioactive with autograft plus bone marrow aspirate to autograft alone for posterolateral spine fusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis
• Spondylolisthesis

Drugs mentioned

• NanOss Bioactive (bone graft substitute)

Snippet

Sponsor: Pioneer Surgical Technology, Inc. | Conditions: Degenerative Disc Disease, Spinal Stenosis | NA | Status: COMPLETED